Article
IL28B polymorphism, pretreatment CXCL10, and HCV RNA levels predict treatment response in racially diverse HIV/HCV coinfected and HCV monoinfected patients.
Journal of acquired immune deficiency syndromes (1999) - 1 May 2013
Zeremski Marija, Dimova Rositsa B, Makeyeva Jessy, Sipley John D, Jacobson Ira M, Rennert Hanna, Talal Andrew H
Abstract excerpt
OBJECTIVE: We sought to develop a score to predict sustained virological response (SVR) in racially diverse HIV/hepatitis C virus (HCV)-coinfected and HCV-monoinfected pegylated interferon/ribavirin-treated patients. METHODS: We retrospectively evaluated 374 patients (259 monoinfected and 115 coinfected) treated at a single tertiary care center. The IL28B rs12979860 single nucleotide polymorphism genotyping was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
